Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
R Rabbie, P Ferguson, C Molina‐Aguilar… - The Journal of …, 2019 - Wiley Online Library
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …
development. Current clinico‐pathologic staging based on the American Joint Committee on …
[引用][C] Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
R Rabbie, P Ferguson, C Molina‐Aguilar… - The Journal of …, 2019 - cir.nii.ac.jp
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic
possibilities | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
possibilities | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[HTML][HTML] Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
R Rabbie, P Ferguson, C Molina‐Aguilar… - The Journal of …, 2019 - ncbi.nlm.nih.gov
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …
development. Current clinico‐pathologic staging based on the American Joint Committee on …
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.
R Rabbie, P Ferguson, C Molina-Aguilar… - The Journal of …, 2019 - europepmc.org
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …
development. Current clinico‐pathologic staging based on the American Joint Committee on …
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
R Rabbie, P Ferguson… - The Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico-pathologic staging based on the American Joint Committee on …
development. Current clinico-pathologic staging based on the American Joint Committee on …
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.
R Rabbie, P Ferguson, C Molina-Aguilar… - The Journal of …, 2019 - europepmc.org
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …
development. Current clinico‐pathologic staging based on the American Joint Committee on …